Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases

Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients

(2013) Gillian Bedard et al.   Asia-Pacific Journal of Clinical Oncology

An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases

(2012) Liang Zeng et al.   SUPPORTIVE CARE IN CANCER

Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients

(2011) J. Maringwa et al.   ANNALS OF ONCOLOGY

The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review

(2011) Andrew Leung et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials

(2010) John T. Maringwa et al.   SUPPORTIVE CARE IN CANCER

The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

(2009) Minesh P. Mehta et al.   JOURNAL OF NEURO-ONCOLOGY

Treating Recurrent Cases of Squamous Cell Carcinoma with Radiotherapy

(2008) Jennifer Jing-Wen Wong et al.   Current Oncology

Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer

(2008) David Cella et al.   VALUE IN HEALTH

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY